An Open-label, Single-center Clinical Trial of [18F]DK222 PET/CT for Imaging of Patients With Non-Small-Cell Lung Cancer (NSCLC) and Urothelial Cancer Who Are Eligible for Treatment With Anti-PD(L)-1
NCT07140315 · RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.